성인 성장호르몬 결핍증의 진단과 치료

키워드

참고문헌 (44)

1. Weaver JU, "The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults", J Clin Endocrinol Metab, 80, pp.153~159 (1995)
2. Beshyah SA, "Cardiovascular disease and risk factors in adults with hypopituitarism", Clin Endocrinol(Oxf), 50, pp.1~15 (1999)
3. Khang AR, "Sex differences in the prevalence of metabolic syndrome and its components in hypopituitary patients : comparison with an age-and sex-matched nationwide control group", Pituitary, 19, pp.573~581 (2016)
4. 김정희, "Diagnosis and Treatment of Growth Hormone Deficiency: A Position Statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology", Endocrinology and Metabolism, 35(2), pp.272~287 (2020), 대한내분비학회[DOI]
5. Yuen KCJ, "American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care", Endocr Pract, 25, pp.1191~1232 (2019)
6. Fleseriu M, "Hormonal replacement in hypopituitarism in adults : an Endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 101, pp.3888~3921 (2016)
7. Molitch ME, "Evaluation and treatment of adult growth hormone deficiency : an Endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 96, pp.1587~1609 (2011)
8. Melmed S, "Pathogenesis and diagnosis of growth hormone deficiency in adults", N Engl J Med, 380, pp.2551~2562 (2019)
9. Molitch ME, "Nonfunctioning pituitary tumors and pituitary incidentalomas", Endocrinol Metab Clin North Am, 37, pp.151~171 (2008)
10. Webb SM, "Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas", J Clin Endocrinol Metab, 84, pp.3696~3700 (1999)
11. Mulder RL, "Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors : a systematic review", Cancer Treat Rev, 35, pp.616~632 (2009)
12. Schneider HJ, "Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage : a systematic review", JAMA, 298, pp.1429~1438 (2007)
13. Hartman ML, "Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?", J Clin Endocrinol Metab, 87, pp.477~485 (2002)
14. Wacharasindhu S, "Normal growth hormone secretion in growth hormone insufficient children retested after completion of linear growth", Clin Endocrinol(Oxf), 45, pp.553~556 (1996)
15. Hamrahian AH, "Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic-pituitary-adrenal axes in adults : results from a prospective randomized multicenter study", Pituitary, 19, pp.332~341 (2016)
16. Garcia JM, "Macimorelin as a diagnostic test for adult GH deficiency", J Clin Endocrinol Metab, 103, pp.3083~3093 (2018)
17. Biller BM, "Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency", J Clin Endocrinol Metab, 87, pp.2067~2079 (2002)
18. Corneli G, "The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index", Eur J Endocrinol, 153, pp.257~264 (2005)
19. Holmes SJ, "Which adults develop side-effects of growth hormone replacement?", Clin Endocrinol(Oxf), 43, pp.143~149 (1995)
20. Hoffman AR, "Efficacy and tolerability of an individualized dosing regimen for adult growth hormone replacement therapy in comparison with fixed body weight-based dosing", J Clin Endocrinol Metab, 89, pp.3224~3233 (2004)
21. Johannsson G, "The individual responsiveness to growth hormone(GH)treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender", J Clin Endocrinol Metab, 81, pp.1575~1581 (1996)
22. Cook DM, "Route of estrogen administration helps to determine growth hormone(GH)replacement dose in GH-deficient adults", J Clin Endocrinol Metab, 84, pp.3956~3960 (1999)
23. Agha A, "Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients", Clin Endocrinol(Oxf), 66, pp.72~77 (2007)
24. Stewart PM, "Growth hormone, insulin-like growth factor-I and the cortisol-cortisone shuttle", Horm Res., 56(Suppl 1), pp.1~6 (2001)
25. Giavoli C, "Effect of recombinant human growth hormone(GH)replacement on the hypothalamic-pituitary-adrenal axis in adult GH-deficient patients", J Clin Endocrinol Metab, 89, pp.5397~5401 (2004)
26. Yang Y, "Efficacy and safety of long-acting growth hormone in children with short stature : a systematic review and meta-analysis", Endocrine, 65, pp.25~34 (2019)
27. "Endocr J", 2015, 1037~1048
28. Colao A, "Impaired cardiac performance in elderly patients with growth hormone deficiency", J Clin Endocrinol Metab, 84, pp.3950~3955 (1999)
29. Rosén T, "Premature mortality due to cardiovascular disease in hypopituitarism", Lancet, 336, pp.285~288 (1990)
30. 최형섭, "성장호르몬 결핍 성인에서 성장호르몬 투여가 심혈관 질환의 표지자에 미치는 영향", 대한내과학회지, 68(5), pp.519~527 (2005), 대한내과학회
31. 김경욱, "성장호르몬 결핍 성인에서 체지방 변화 이상의 성장호르몬 치료 효과", Journal of Obesity & Metabolic Syndrome, 22(1), pp.56~65 (2013), 대한비만학회
32. Götherström G, "Ten years of growth hormone(GH)replacement normalizes muscle strength in GH-deficient adults", J Clin Endocrinol Metab, 94, pp.809~816 (2009)
33. Pappachan JM, "Excess mortality associated with hypopituitarism in adults : a meta-analysis of observational studies", J Clin Endocrinol Metab, 100, pp.1405~1411 (2015)
34. van Bunderen CC, "Growth hormone deficiency and replacement therapy in adults : impact on survival", Rev Endocr Metab Disord, 22, pp.125~133 (2021)
35. Vestergaard P, "Fracture risk is increased in patients with GH deficiency or untreated prolactinomas--a case-control study", Clin Endocrinol(Oxf), 56, pp.159~167 (2002)
36. Mo D, "Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency : a prospective observational cohort study", Lancet Diabetes Endocrinol, 3, pp.331~338 (2015)
37. Björk S, "Quality of life of adults with growth hormone deficiency : a controlled study", Acta Paediatr Scand Suppl, 356, pp.55~74 (1989)
38. Svensson J, "Three-years of growth hormone(GH)replacement therapy in GH-deficient adults : effects on quality of life, patient-reported outcomes and healthcare consumption", Growth Horm IGF Res, 14, pp.207~215 (2004)
39. Boguszewski CL, "Growth hormone's links to cancer", Endocr Rev, 40, pp.558~574 (2019)
40. Ergun-Longmire B, "Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor", J Clin Endocrinol Metab, 91, pp.3494~3498 (2006)
41. Olsson DS, "Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy", Eur J Endocrinol, 161, pp.663~669 (2009)
42. Sklar CA, "Hypothalamic-pituitary and growth disorders in survivors of childhood cancer : an Endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 103, pp.2761~2784 (2018)
43. Yuen KC, "Impact of treatment with recombinant human GH and IGF-I on visceral adipose tissue and glucose homeostasis in adults", Growth Horm IGF Res, 16(Suppl A), pp.S55~S61 (2006)
44. al-Shoumer KA, "Effects of four years' treatment with biosynthetic human growth hormone(GH)on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults", Clin Endocrinol(Oxf), 48, pp.795~802 (1998)

관련 논문AI추천